Fingerprint
Dive into the research topics of 'Nivolumab and ipilimumab versus ipilimumab in untreated melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
Michael A. Postow, Jason Chesney, Anna C. Pavlick, Caroline Robert, Kenneth Grossmann, David McDermott, Gerald P. Linette, Nicolas Meyer, Jeffrey K. Giguere, Sanjiv S. Agarwala, Montaser Shaheen, Marc S. Ernstoff, David Minor, April K. Salama, Matthew Taylor, Patrick A. Ott, Linda M. Rollin, Christine Horak, Paul Gagnier, Jedd D. Wolchok
Research output: Contribution to journal › Article › peer-review
2290
Scopus
citations